Birch Bark

What is Birch Bark?

Birch bark reaches the consumer as two products that share a name and almost nothing else. The first is a triterpene extract from the papery outer bark of Betula pendula and Betula pubescens, roughly 20 to 30 percent betulin by dry mass of that layer and occasionally near 45 percent, approved as a prescription drug in the European Union on 21 June 2022 and in the United States on 18 December 2023 under the brand Filsuvez. The second is sweet birch oil, steam distilled from Betula lenta, which analytical surveys put at 93 to 99 percent methyl salicylate. One is a wound gel costing about 81 dollars a gram. The other is a 15 mL bottle of something chemically indistinguishable from concentrated aspirin precursor, sold without a dosing device.

Common Names

• Silver birch (Betula pendula Roth, formerly B. verrucosa) and downy birch (Betula pubescens Ehrh.), the two pharmaceutical species

• Sweet birch, black birch, cherry birch (Betula lenta L.), the essential oil species. Yellow birch (Betula alleghaniensis), paper birch (Betula papyrifera) and Asian white birch (Betula platyphylla) appear in the wider literature

• Betulae cortex (bark), Betulae folium (leaf), birch tar, birch sap, "birch sugar" as a marketing name for xylitol

• Birch triterpenes, Oleogel-S10, Filsuvez for the pharmaceutical extract; sweet birch oil, oil of betula, and, incorrectly, "wintergreen oil" for the distillate

Primary Active Compounds

• Betulin, C30H50O2, molar mass 442.7 g/mol, first isolated in 1788 by Johann Tobias Lowitz. The dominant pentacyclic triterpene of outer bark and 72 to 88 percent w/w of the Filsuvez active substance

• Betulinic acid, the C-28 carboxylic acid analogue, 2.6 to 4.2 percent of that drug substance and a much smaller fraction of raw bark. Alongside it, lupeol 2.4 to 5.7 percent, erythrodiol 0.5 to 1.2 percent, oleanolic acid 0.3 to 0.8 percent

• Methyl salicylate, CAS 119-36-8, molar mass 152.15 g/mol, density 1.174 g/mL at 25 degrees C. Present in Betula lenta bark as the glycoside gaultherin, not as free ester

• Suberin in the outer bark, salicylate glycosides and flavonoids in inner bark and leaf

Key Note

Betula lenta bark does not contain free methyl salicylate while the tree is alive. It contains gaultherin, also called monotropitoside, a salicylate glycoside. Maceration in warm water lets a native enzyme cleave the sugar, and only then does steam distillation liberate the ester. The commercial oil is a manufactured chemical event rather than a substance sitting in a tree.

Birch is the rare case where the pharmaceutical version of a plant is the gentle one and the health-food-store version is the one that kills children.

Primary Functions & Benefits

Birch products divide cleanly by preparation, and the evidence divides with them.

Triterpene extract, topical, wound healing

The only birch preparation with a regulatory approval anywhere. Filsuvez is indicated for partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa in patients 6 months and older. That narrow indication is the entire proven clinical benefit of the genus.

Methyl salicylate, topical, counterirritant analgesia

Local vasodilation, a warming sensation that competes with pain signaling, and a modest anti-inflammatory contribution from absorbed salicylate. FDA's OTC Monograph M017 lists methyl salicylate 10 to 60 percent as a counterirritant active ingredient, which is why the concentration is regulated at all.

Birch leaf, traditional aquaretic

The EMA Committee on Herbal Medicinal Products adopted a monograph for Betulae folium on 20 October 2015, document EMA/482160/2015, covering Betula pendula, Betula pubescens and hybrids, for increasing urine flow in minor urinary complaints in adults and adolescents over 12. It is registered on traditional use, and HMPC stated plainly that the available clinical data are too limited to serve as evidence.

Betulin and betulinic acid, systemic

Extensive in-vitro and rodent work. No human efficacy result, covered in Section 20.

Forms & Standardization

Pharmaceutical triterpene dry extract (Filsuvez / Oleogel-S10)

The most tightly specified birch preparation in existence. Active substance: dry extract from birch bark, drug-to-extract ratio 5 to 10 : 1, extraction solvent n-heptane 95 percent w/w. The finished gel contains 100 mg of birch triterpenes per gram, the remaining roughly 90 percent refined sunflower oil, no other excipients. The triterpene fraction is specified as betulin 72 to 88 percent, lupeol 2.4 to 5.7 percent, betulinic acid 2.6 to 4.2 percent, erythrodiol 0.5 to 1.2 percent, oleanolic acid 0.3 to 0.8 percent. Run the arithmetic on a 23.4 g tube: 2.34 g of extract, representing roughly 12 to 23 g of dried outer bark, at about 80.83 dollars per gram of gel.

Dietary-supplement betulin

Sold as capsules typically at 50 mg, and as bulk powder marketed at 90, 95 or 98 percent betulin. There is no compendial monograph, no USP standard and no human dose-finding study behind any of those numbers, so purity claims in this tier are supplier assertions. Published purification work using recrystallization from n-nonane or n-decane reaches 88 to 98 percent, so the grades are achievable, but nothing verifies that a given lot met them.

Crude bark powder and bark tea

Standardized to nothing. Betulin is essentially insoluble in water, so a decoction delivers a trivial fraction of the triterpene content regardless of how much bark went in. What the water does extract is salicylate glycosides, tannins and flavonoids, none of them quantified on any label.

Sweet birch essential oil (Betula lenta) and wintergreen oil (Gaultheria procumbens)

Both are single-chemical products sold without being described as one, typically in 10 or 15 mL amber dropper bottles. Authentic sweet birch is 93 to 99 percent methyl salicylate with minor ethyl salicylate and methyl o-anisate; wintergreen is 96 to 99 percent of the same ester. They are traded interchangeably and neither price nor label reliably distinguishes them. Whether the bottle on the shelf is birch at all is covered in Section 18.

Non-triterpene birch products

Birch tar is a destructive distillation product carrying phenols and polycyclic aromatic hydrocarbons. Birch sap is discussed in Section 5. Xylitol, marketed as "birch sugar," is a sugar alcohol made by hydrogenating xylose from hemicellulose; birch xylan was the original feedstock but most production now runs on corn cobs, so the name is heritage rather than a sourcing claim. None of the three contains meaningful betulin.

Food Sources

Birch is not a meaningful dietary source of anything.

Birch sap

The one genuinely edible birch product. Per 100 g it supplies roughly 120 mg potassium, 11 mg calcium, 6.4 mg phosphorus and 1.1 mg magnesium, with trace vitamin C and B vitamins. Potassium at 120 mg per 100 g is real but unremarkable; a medium banana carries about 420 mg. Sugar runs near 1 percent, fructose at 42 to 54 percent of it and glucose at about 45 percent, so a 250 mL glass delivers roughly 2.5 g. The tapping window is about one month a year, before leaf-out, and 130 to 150 liters reduce to 1 liter of syrup against about 40 for maple.

Wintergreen and birch as flavorings

Methyl salicylate is a permitted flavoring at very low levels in confectionery, chewing gum and root beer, which is the origin of the entire safety problem. 21 CFR 201.303 says so in its own reasoning: the substance is "quite toxic when taken in quantities of a teaspoonful or more" while the public thinks of it as harmless because of its use as a flavoring.

Bottom line on food

Inner bark was ground into famine flour in Scandinavia, which is history rather than a recommendation. There is no food route to a pharmacologically relevant dose of betulin, and the one birch preparation that reliably delivers a drug dose is the one you must not swallow.

Who Should Take Birch Bark

People with dystrophic or junctional epidermolysis bullosa

The only group with trial evidence supporting use, and only for the prescription gel, only topically, only under specialist care. Filsuvez is approved from 6 months of age.

People using a topical salicylate rub for musculoskeletal pain

Rubs at monograph concentrations are a reasonable option for localized muscle and joint pain in adults, provided the user is not on an anticoagulant, is not aspirin-sensitive, and does not combine the product with heat or occlusion.

Everyone else

Betulin has never been tested for efficacy in a human being for any indication, so anyone taking capsules is acting on mouse and cell-culture data. As for swallowing the essential oil, no one should: there is no appropriate dose of undiluted methyl salicylate, and the margin between a flavoring quantity and a toxic quantity is a few milliliters.

Who Should AVOID or Use Caution

Contraindications

• Children under 6, for any concentrated methyl salicylate product. The American Academy of Clinical Toxicology consensus guideline sets the referral threshold for this group at more than a lick or taste of 98 percent oil of wintergreen. The EU banned methyl salicylate outright in cosmetics for children under 6 under Commission Regulation (EU) 2022/1531 of 15 September 2022, applicable from 17 December 2022, toothpaste excepted

• Aspirin or NSAID hypersensitivity, including salicylate-sensitive asthma. Methyl salicylate is hydrolyzed to salicylate and will provoke the same reaction

• Anyone on warfarin or another vitamin K antagonist, for topical methyl salicylate. Ramanathan, Medical Journal of Malaysia 1995, volume 50 number 3, reported a 25-year-old on 2 mg warfarin daily whose INR reached 16 with gum bleeding and a leg hematoma after months of daily salicylate liniment massage, and a 57-year-old whose INR rose from a 2.0 to 2.5 baseline to 3.5. Joss and LeBlond, Annals of Pharmacotherapy 2000, reported the same interaction

• Broken or damaged skin, where absorption is unpredictable and the monograph warning is explicit, and children or teenagers with viral illness, given the salicylate-Reye syndrome association

Use Caution

• Birch pollen allergy. Bet v 1 is the major birch allergen and drives the birch-fruit oral allergy syndrome through PR-10 cross-reactivity with apple, cherry, hazelnut, carrot and celery. Bark is a different tissue and lower risk, but a pollen-allergic patient reacting to a birch product is not implausible

• Athletes and anyone applying a salicylate rub around exercise. Heat, sweat, exertion and occlusive wraps all increase percutaneous absorption, as does application over a large surface area or more than the labeled four times daily

• Pregnancy, for all systemic salicylate exposure, and for birch supplements generally

Critical Safety Point

Arielle Newman, a 17-year-old cross-country runner at Notre Dame Academy on Staten Island, died on 3 April 2007 from methyl salicylate toxicity caused by repeated heavy application of over-the-counter muscle creams. The New York City Office of Chief Medical Examiner recorded it as its first fatality from topical sports-cream use. She did not swallow anything. Absorption through intact skin, over a large area, in an athlete generating heat and blood flow, was sufficient. Bengay Ultra Strength carries 30 percent methyl salicylate, 10 percent menthol and 4 percent camphor, and a single 5 g application puts 1,500 mg of the ester on the skin.

Recommended Dosages

Prescription triterpene gel (Filsuvez)

A layer approximately 1 mm thick over the whole wound surface at each dressing change. Not a self-directed dose. Wound area and dressing frequency set consumption, which is why extensive disease consumes 23.4 g tubes quickly.

Topical methyl salicylate rub

FDA Monograph M017 permits methyl salicylate 10 to 60 percent as a counterirritant, applied not more than 3 to 4 times daily. Do not use on children under 2 without a physician, do not bandage tightly, do not apply heat.

Sweet birch essential oil

Diluted for topical use, common practice is 1 to 2 percent in a carrier, putting a 1 percent blend at roughly 11.7 mg of methyl salicylate per mL. Even there it is a salicylate drug and the anticoagulant and aspirin-allergy cautions apply. Internally there is no dose. Zero milliliters. The clinical toxicology out-of-hospital guideline triages any ingestion above a lick or taste in a child under 6, and above 4 mL in anyone 6 or older, straight to an emergency department.

Betulin capsules and birch leaf

Betulin is typically marketed at 50 mg once or twice daily, a number not derived from any human study. There is no established human dose, no blood level target, and no human efficacy endpoint. Birch leaf is taken as an infusion of dried leaf by adults and adolescents over 12 with adequate fluid intake.

Duration

Filsuvez was studied continuously to 24 months in the EASE open-label phase, mean treatment duration 584.7 days. Topical counterirritant rubs carry a 7-day self-treatment limit under the monograph. Birch leaf carries a 2 to 4 week traditional-use limit. Betulin supplements have no studied duration in humans, short or long.

Timing & Administration

The gel goes onto the wound bed at every dressing change, applied to the wound and immediately surrounding skin and left under a non-adhesive dressing rather than rubbed in.

Topical salicylate rubs should go onto cool, dry, intact skin and be allowed to absorb before dressing. The single most avoidable error is combining a rub with a heating pad, a hot bath, or plastic wrap, each of which raises systemic uptake over the 12 to 20 percent of applied methyl salicylate that Anderson and colleagues reported as absorbed within the first 10 hours in Medicines 2017, volume 4, article 48. Wash hands afterward: hand-to-eye transfer is intensely irritating, and hand-to-mouth transfer in a household with small children is a documented exposure route.

Birch leaf infusion is taken through the day with generous fluid intake, since the intended effect is flushing. Betulin capsules have no evidence-based timing.

Timeline of Effects

Topical methyl salicylate

The counterirritant warming begins within 5 to 15 minutes and is the effect people are actually paying for. Systemic salicylate takes days, and this is the part users do not see. Repeated twice-daily application of a methyl salicylate ointment in volunteers produced serum salicylate concentrations of 2 to 6 mg/L by day 4. Those levels are low, and they are also evidence that the compound accumulates with repeat dosing rather than clearing between applications.

Filsuvez wound closure

The EASE primary endpoint was first complete closure of a target wound within 45 days, and the 24-month open-label phase showed reductions in affected body surface area of 3.7 to 5.9 percentage points. Forty-five days is the fair-trial window regulators accepted, and it is short only relative to how long these wounds otherwise persist.

Birch leaf and betulin

Birch leaf acts within hours, with the HMPC setting 2 to 4 weeks as the limit for self-treatment. Betulin supplements have no timeline because they have no human endpoint. The six-week mouse study by Tang and colleagues in Cell Metabolism 2011, volume 13, pages 44 to 56, is the source of most consumer claims about betulin and cholesterol, and six weeks in a mouse is not a timeline for a person.

Benefits of Taking Birch Bark

Wound closure in epidermolysis bullosa, proven

The EASE trial randomized 223 patients, 109 to Oleogel-S10 and 114 to control gel, median age 12 years, range 6 months to 81 years, 70 percent under 18. First complete closure of the target wound within 45 days occurred in 41.3 percent on birch gel versus 28.9 percent on control, a difference of 12.4 percentage points, 95 percent confidence interval 0.8 to 25.6. That interval comes close enough to zero to be worth saying out loud: the effect is real, significant, and modest.

Subgroup detail that a marketing page will not show you

Recessive dystrophic EB, n = 175: 44.0 percent versus 26.2 percent. Dominant dystrophic EB, n = 20: 50.0 percent versus 50.0 percent, no separation at all. Junctional EB, n = 26: 18.2 percent versus 26.7 percent, numerically worse than control. The approved indication covers junctional EB on the strength of the overall population, and the honest reading is that essentially all of the observed benefit came from the recessive dystrophic group.

Everything else

Counterirritant analgesia from methyl salicylate is settled within its drug class, which is why the ingredient sits in an FDA monograph rather than in a supplement. Birch leaf is registered on traditional use, explicitly not on clinical data. Anticancer, antiviral, hepatoprotective, antidiabetic and anti-obesity claims for betulin and betulinic acid rest entirely on cell and animal work.

Potential Negatives & Side Effects

Filsuvez

The most common adverse reactions at 2 percent or greater incidence were application-site reactions, including pruritus and pain. In the 24-month open-label phase covering 205 patients, 77.1 percent had an adverse event, mostly mild to moderate, 24.4 percent had a serious adverse event, and 7.8 percent discontinued. Nine deaths occurred, none attributed to treatment. Four squamous cell carcinomas were reported in recessive dystrophic EB patients during the randomized trial, a known background risk in that population rather than an established drug effect, and the label discloses it.

Methyl salicylate products

Local burning, erythema and contact dermatitis are common with rubs, and chemical burns are documented, particularly with occlusion or heat. Undiluted oil causes irritation and sensitization at minimum. Systemic effects are the real concern and are covered in Section 14.

Birch leaf and betulin supplements

Birch leaf is generally well tolerated, with gastrointestinal upset and allergic reactions in the HMPC assessment. For betulin, no systematic human safety data exists at any dose, which is not the same as none being needed.

Deficiency Symptoms

Birch bark is not an essential nutrient, so no deficiency state exists, and nothing in the genus performs a required biological function in a human being.

What birch addresses

Betulin gel treats a wound. Methyl salicylate treats a pain signal. Birch leaf increases urine volume. None corrects a shortfall, and none will do anything in a person who does not have the corresponding problem.

Bottom line

Iodine is the useful contrast: a measurable intake threshold separates a healthy thyroid from a goiter. There is no birch equivalent of that threshold, no blood marker of birch status, and no birch-deficient population. Any product implying you are missing something birch supplies is describing a deficiency that does not exist.

Toxicity Symptoms

At high intake

Methyl salicylate toxicity is salicylate toxicity with a faster onset. The salicylate risk bands used in emergency medicine, expressed as aspirin equivalent, are under 150 mg/kg minimal, 150 to 300 mg/kg mild to moderate, above 300 mg/kg severe, above 500 mg/kg potentially lethal. Now apply the arithmetic from Section 2. A 5 mL teaspoon of 98 percent oil is roughly 6,800 mg of aspirin equivalent. In a 10 kg toddler that is about 680 mg/kg, above the potentially lethal band on a single swallow. In a 70 kg adult the same teaspoon is about 97 mg/kg, below the mild band. That difference in body mass is why the pediatric literature is so grim while adult ingestions of the same volume often are not.

The AACT and EAPCCT consensus guideline records fatalities in children under 6 at ingestions as low as approximately 5 mL, and cites two fatal cases in 2-year-olds at 10 mL, an aspirin-equivalent dose of 14 g or 959 mg/kg, and at 15 mL, 21 g or 1,438 mg/kg. Anderson and colleagues report that about 77 percent of methyl salicylate poisoning enquiries involve children under 6, and that the compound remains a regular feature of the US National Poison Data System.

Signs to reduce or stop

• Tinnitus and hearing changes, the classic early salicylate signal

• Nausea, vomiting, sweating, hyperventilation from direct respiratory-center stimulation

• Dizziness, confusion, lethargy

• Seizures and coma in severe cases, with mixed respiratory alkalosis and metabolic acidosis on blood gas

General note

Realistic topical exposure is a different order of magnitude from ingestion, and this deserves stating precisely rather than dramatically. A 5 g application of a 30 percent rub places 1,500 mg of methyl salicylate on the skin. At the 12 to 20 percent absorption reported over 10 hours, that is roughly 180 to 300 mg absorbed, about 210 to 355 mg of aspirin equivalent, close to a single adult tablet. Used as labeled on one sore shoulder, a salicylate rub is a low-risk product. The fatal exposures in the literature all cluster at the other end: large surface area, high frequency, heat, occlusion, or a swallowed teaspoon. The product is safe as directed and lethal in a way most users would never guess when it is not.

How Birch Bark Works

Betulin and the triterpene fraction in wound repair

The proposed mechanism for Oleogel-S10 is modulation of inflammatory mediators and acceleration of keratinocyte migration across the wound bed, with in-vitro work showing effects on cytokine release and on the actin cytoskeleton reorganization that lets keratinocytes crawl. The vehicle matters as much as the chemistry: 90 percent refined sunflower oil forms an occlusive film that keeps the wound moist and releases at dressing change without shearing new blisters. That mechanism has never been isolated from the vehicle clinically, so how much of the 12.4 percentage point difference is triterpene and how much is oil film remains open.

Methyl salicylate as a prodrug

Methyl salicylate is the methyl ester of salicylic acid, small, uncharged and highly lipophilic, which is why it crosses the stratum corneum readily where salicylic acid does not. Once through, esterases in skin, blood and liver hydrolyze it, and from there it does what a dose of aspirin does after its own hydrolysis: inhibits cyclooxygenase, uncouples oxidative phosphorylation at high concentration, and stimulates the medullary respiratory center. The molar bookkeeping is the part worth memorizing. Methyl salicylate at 152.15 g/mol yields salicylic acid at 138.12 g/mol, a factor of 0.908, and corresponds to aspirin at 180.16 g/mol by a factor of 1.184. Multiply by the 1.174 g/mL density and 98 percent purity and you land on 1.36 to 1.4 g of aspirin equivalent per milliliter. Elimination then saturates: salicylate follows zero-order kinetics once glycine conjugation is overwhelmed, which is why doubling the dose can more than double the peak and why repeated topical application accumulates instead of clearing between doses.

Betulinic acid in cell culture

Betulinic acid triggers apoptosis by acting directly on mitochondria, causing cytochrome c release and caspase activation independently of p53. That is the mechanism behind three decades of laboratory papers, and Section 20 covers why it has never reached a person.

Synergistic Supplements

There are no established synergies for birch preparations, so there is little to put here.

• Sunflower oil with birch triterpenes. Not a supplement pairing but the only combination with regulatory backing. The 10 percent extract in 90 percent refined sunflower oil is the tested product, and the vehicle is inseparable from the result

• Menthol and camphor with methyl salicylate. Standard in commercial rubs at 10 percent and 4 percent alongside 30 percent methyl salicylate. Additive counterirritation, not pharmacological synergy, and each carries its own ceiling under Monograph M017

• What to avoid stacking. Any other salicylate source. Aspirin, salsalate, bismuth subsalicylate, willow bark, meadowsweet and wintergreen all feed the same salicylate pool, and a person using several is dosing one drug from several bottles

Interactions & What NOT to Take

• Warfarin and other vitamin K antagonists. The best-documented and most dangerous interaction. Two published case series show clinically significant potentiation from topical methyl salicylate alone, including an INR of 16. Salicylate displaces warfarin from albumin and independently inhibits platelet function

• Aspirin and other salicylates. Additive. A person on cardioprotective aspirin who applies a 30 percent rub daily is adding a variable, unmeasured second dose

• NSAIDs. Additive gastrointestinal and renal risk, particularly in older adults with reduced renal function

• Methotrexate. Salicylates reduce its renal clearance and raise the risk of methotrexate toxicity

• Sulfonylureas. Salicylates can potentiate hypoglycemia

• Acetazolamide and other carbonic anhydrase inhibitors. Interaction with salicylate acid-base handling can worsen toxicity

• Heparin, direct oral anticoagulants, clopidogrel. Additive bleeding risk

• Heating pads, hot tubs, saunas, occlusive wraps and vigorous exercise. Not drugs, but the most common route to an unintended systemic dose from a topical product

• Filsuvez specifically. No formal drug interaction studies were conducted. Minimal systemic triterpene exposure is the basis for the absence of interaction warnings, which is not the same as a positive finding of safety

Quality, Testing & Adulteration

The sweet birch oil market survey

Dosoky, Poudel and Satyal, Plants 2022, volume 11, article 2132, identified four chemical markers found in authentic Betula lenta oil and not in wintergreen or synthetic material: o-guaiacol, veratrole, 2E,4Z-decadienal and 2E,4E-decadienal. They characterized 21 authentic samples, 18 industrially distilled and 3 laboratory-extracted, then bought 27 commercial "birch" oils from US online vendors.

None of the 27 contained any birch marker. Not one.

What they found instead: wintergreen markers in 13 samples, vitispirane in 10 and beta-dehydroelsholtzia ketone in 3. A marker of synthetic methyl salicylate, dimethyl 2-hydroxyterephthalate, in 6. A castor oil marker, ricinelaidic acid lactone, in 1. The entire retail category, as sampled, was wintergreen, synthetic ester, or something cut with a cheap carrier, sold as sweet birch.

Why this happens

Steam-distilling Betula lenta is slow and low-yielding, the tree has to be cut or heavily stripped, and the finished chemical is identical to a synthetic costing a fraction as much. There is no difference in the main constituent to expose the swap, which is why marker compounds and carbon isotope ratio methods had to be developed at all.

What a certificate of analysis should show for essential oil

• Species by binomial name and plant part, with the distiller or country of origin, and a batch number tied to a date within the lot's shelf life

• Full GC-MS profile, not a methyl salicylate assay. A single-number assay cannot distinguish birch from wintergreen from synthetic

• Presence or absence of the four birch markers above, plus carbon isotope ratio data, if the seller claims Betula lenta and natural origin

What a certificate should show for a betulin supplement

• HPLC assay of betulin with the actual percentage, method reference and a chromatogram, plus separate quantification of betulinic acid and lupeol, since a betulin claim can be met by total triterpene content

• Species and geographic origin of the bark, which drives betulin content from around 20 percent to nearly 45 percent of outer bark dry mass, and residual solvent testing, since industrial extraction uses heptane, petroleum ether, toluene or acetone

What a buyer can actually verify

Nothing specific to birch exists in third-party certification: no USP monograph for betulin or birch bark extract, no NSF category, no ConsumerLab report. For the essential oil a buyer can verify almost nothing without a lab, which given a 0-for-27 authentication rate is a serious problem. For the prescription gel, everything, because it is a drug with an approved specification. The gap between those two is the whole issue.

Special Considerations

Pregnancy and lactation

Third-trimester systemic salicylate exposure is associated with premature closure of the ductus arteriosus, and a topical route does not make that risk vanish. Filsuvez has no adequate human data and birch supplements have no reproductive data at all.

Children, and the regulatory split

Bengay Ultra Strength and comparable products carry a "do not use on a child under 12 years of age with arthritis-like conditions" instruction, and Monograph M017 sets a "do not use, consult a physician" for children under 2. The EU cosmetics restriction bans methyl salicylate for children under 6 entirely, toothpaste excepted, and sets limits as low as 0.002 percent in eye makeup and 0.06 percent in leave-on skin products, against the 10 to 60 percent permitted in an American OTC rub. Same molecule, two regulators, three orders of magnitude apart.

Household storage

16 CFR 1700.14(a)(3) requires child-resistant packaging for liquid preparations containing more than 5 percent methyl salicylate by weight, pressurized sprays exempted; aspirin falls under 16 CFR 1700.14(a)(1). Both are covered, and the practical difference is that aspirin arrives as countable tablets while a 15 mL oil bottle arrives with an orifice reducer and a screw cap a determined 3-year-old can open. The regulation is met. The risk is not equalized.

Cost, and one unrelated hazard

Filsuvez runs roughly 1,891 dollars per 23.4 g tube with consumption driven by wound area rather than a fixed dose, so annual cost in extensive disease is substantial and reimbursement varies by country and payer. Separately, and nothing to do with birch chemistry: xylitol causes insulin release and severe hypoglycemia in dogs at doses well below human relevance, so a jar labeled "birch sugar" in a kitchen with a dog is a hazard whatever the feedstock was.

Research Status & Evidence Quality

Strong Evidence For

• Nothing in oral or supplement form, for any indication. Topical methyl salicylate works as a counterirritant analgesic, but that is established for the drug class and regulated as such, which is a different claim from evidence for birch as a botanical

Moderate Evidence For

• Oleogel-S10 for wound closure in epidermolysis bullosa. One adequately powered randomized double-blind phase 3 trial, EASE, n = 223, primary endpoint met at 41.3 percent versus 28.9 percent with a 95 percent confidence interval of 0.8 to 25.6 on the difference. Approved in the EU on 21 June 2022 and by FDA on 18 December 2023 under NDA 215064, submitted 30 March 2021 from an IND effective 8 September 2018. A real result, from a single trial, with essentially all of the effect in the recessive dystrophic subgroup

Emerging / Preliminary Evidence For

• Betulinic acid as a selective cytotoxic agent. Pisha and colleagues, Nature Medicine 1995, volume 1, pages 1046 to 1051, identified betulinic acid from birch bark as a melanoma-selective apoptosis inducer with complete tumor growth inhibition in mouse xenografts and no observed toxicity. That paper is three decades old and has generated hundreds of in-vitro follow-ups and multiple synthetic derivatives. It has never produced a human efficacy result in any cancer, no betulinic acid product has completed a phase 3 oncology trial, and the compound is not an approved anticancer agent anywhere

• Betulin and metabolic disease. Tang and colleagues, Cell Metabolism 2011, volume 13, pages 44 to 56, showed betulin inhibits SREBP maturation, lowering cholesterol, limiting diet-induced obesity and reducing atherosclerotic plaque in mice over six weeks. No human trial has tested it

• Antiviral, hepatoprotective, antidiabetic and anti-inflammatory activity for birch triterpenes. Preclinical throughout

Research Limitations

• The thirty-year gap has a structural cause. Betulin and betulinic acid are almost insoluble in water and need nanoemulsion or amorphous solid dispersion formulation to reach usable blood levels even in animals. A compound that cannot be delivered cannot be tested, and one never tested in people cannot support a human claim no matter how many cell lines it kills

• EASE is one trial, its confidence interval on the primary endpoint runs from 0.8 to 25.6 percentage points, and no second trial has been run. The junctional EB subgroup, n = 26, showed 18.2 percent closure on drug versus 26.7 percent on control, yet the approved indication covers that group on the pooled result rather than its own data

• Birch leaf is registered on traditional use because the HMPC found the clinical data too limited to serve as evidence. That is a regulatory category, not a finding of efficacy

• No human dose-ranging study establishes an oral betulin dose, so every 50 mg capsule on the market carries a number chosen by a manufacturer

Summary & Key Takeaways

Birch is a genus where the drug and the supplement have swapped their expected roles. The prescription extract went through an IND, a 223-patient randomized trial and two regulatory reviews to earn a narrow indication with a modest effect size. The health-food product, sweet birch essential oil, is 93 to 99 percent of a single drug molecule, sold without a dose, without a measuring device, and, per the only published market authentication study, without actually being birch in any of 27 samples tested.

Bottom Line

If you have epidermolysis bullosa, birch triterpene gel is a real treatment with a modest single-trial benefit concentrated in recessive dystrophic disease. If you want a salicylate rub, buy the regulated 10 to 60 percent product with the monograph warnings on it, not the 98 percent bottle from the aromatherapy shelf. If you are considering betulin capsules for cholesterol, metabolism or cancer, the evidence base is mice and cell culture, three decades deep and zero humans wide.

Key Safety Points

• One 5 mL teaspoon of sweet birch or wintergreen oil is roughly 6,800 to 7,000 mg of aspirin equivalent, about 21 to 22 standard 325 mg tablets. In a 10 kg child that is about 680 mg/kg, above the 500 mg/kg potentially lethal salicylate band

• Documented pediatric fatalities have occurred at ingestions as low as approximately 5 mL, with two recorded deaths in 2-year-olds at 10 mL and 15 mL

• Topical methyl salicylate killed a 17-year-old athlete in Staten Island in April 2007 through repeated heavy application, no ingestion involved. Used as labeled, though, a 30 percent rub delivers only about 210 to 355 mg of aspirin equivalent per application. Heat, occlusion, large surface area and high frequency are what turn it dangerous

• Anyone on warfarin should treat a salicylate rub as a drug interaction, not a toiletry. Published INR values reached 16

Special Note

Purification is a safety technology, and that lesson transfers to any shelf where a botanical and a pharmaceutical share a molecule. Aspirin exists in a 325 mg tablet not because the dose is small but because someone had to decide what the dose was, print it, and package it so the decision could not be casually exceeded. Sweet birch oil skipped every one of those steps and arrived at 98 percent purity anyway. When a natural product and a drug share an active compound, the question is never which one is stronger. It is which one has a number on the label and a lid you have to think about.